Stock-Encyclopedia.com

U.S.-Listed ETF listed on a U.S. stock exchange



The ETF: BioShares Biotechnology Clinical Trials Fund (BBC)

 

Categories:

All ETFs  >  Stock ETFs  >  By Industry  >  Technology  >  Biotechnology
Advertisement        


BioShares Biotechnology Clinical Trials Fund
The objective of the BioShares Biotechnology Clinical Trials Fund is to invest in biotechnology companies with lead drugs in human clinical trials stage. Clinical Trials stage companies are typically younger, smaller companies that do not have a drug approved, but instead focus on testing their experimental drug candidates in human clinical trials. Successful companies prudently manage their balance sheets through financings and partnerships in order to develop their potential blockbuster drugs.

Investment type: ETF (Exchange-Traded Fund); listed on the U.S. NYSE exchange

Ticker symbol: BBC

Fund manager: BioShares

Fund information from BioShares: BioShares Biotechnology Clinical Trials Fund

Fund launched:



ETF charts and further information:
NYSE

Delayed Quote
SEC Filings
Bloomberg

Delayed quote
Charting
Yahoo

RT quote
Charting
Headlines
Boards
Google

RT quote
Charting
Headlines
Discussion
MSN Money

RT quote
Charting
Options
Motley Fool

Delayed quote
Analysis
SEC Filings
Community
Seeking Alpha

Delayed quote
Analysis
StockCharts

Daily charts
 

 
 

 

Disclaimers:
• Information on this website should not be considered to be investment advice. Any ETF can go DOWN as well as up.
• Information on this website should not be assumed to be complete or correct. Funds can also change their investment goals. That's why, wherever possible, we provide links to the actual fund sponsor and the exchange on which the fund trades.

Created by Specifica, Inc.: Original content and unique compilation of information are copyright 2007-2015.